Erika Pollex

596 total citations
12 papers, 404 citations indexed

About

Erika Pollex is a scholar working on Oncology, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Erika Pollex has authored 12 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Obstetrics and Gynecology and 3 papers in Surgery. Recurrent topics in Erika Pollex's work include Pregnancy and preeclampsia studies (4 papers), Gestational Diabetes Research and Management (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Erika Pollex is often cited by papers focused on Pregnancy and preeclampsia studies (4 papers), Gestational Diabetes Research and Management (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Erika Pollex collaborates with scholars based in Canada, United Kingdom and United States. Erika Pollex's co-authors include Gideon Koren, Denice S. Feig, Janine R. Hutson, Paul S. F. Yip, Myla E. Moretti, Micheline Piquette‐Miller, G Anger, Irene Cybulsky, Joel G. Ray and Cindy Hamielec and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Drug Metabolism and Disposition.

In The Last Decade

Erika Pollex

12 papers receiving 391 citations

Peers

Erika Pollex

ONCOL

SURGE

PPCH

PHEOH

Ivan Jakopčić Croatia

Juhani S. Koskinen Finland

Caroline Ovadia United Kingdom

S S Entman United States

Neera Agarwal India

E Ikonen Finland

Szu‐Chi Chen Taiwan

Ayşe Gül Kebapçılar Türkiye

Olimpia Diadei Italy

G. A. Murnaghan United Kingdom

Ivan Jakopčić Croatia

Erika Pollex

38 ×0.2

52 ×0.4

ONCOL

151 ×1.2

SURGE

31 ×0.3

PPCH

35 ×0.4

PHEOH

Citations per year, relative to Erika Pollex Erika Pollex (= 1×) peers Ivan Jakopčić

Countries citing papers authored by Erika Pollex

Since Specialization

Citations

This map shows the geographic impact of Erika Pollex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Pollex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Pollex more than expected).

Fields of papers citing papers by Erika Pollex

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Pollex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Pollex. The network helps show where Erika Pollex may publish in the future.

Co-authorship network of co-authors of Erika Pollex

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Pollex. A scholar is included among the top collaborators of Erika Pollex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Pollex. Erika Pollex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Cortés, Javier, Fabrice André, Anthony Gonçalvès, et al.. (2019). Impassion132 Phase Iii Trial: Atezolizumab And Chemotherapy In Early Relapsing Metastatic Triple-Negative Breast Cancer. Future Oncology. 15(17). 1951–1961. 57 indexed citations

Dent, Rebecca, Fabrice André, Anthony Gonçalvès, et al.. (2018). IMpassion132: A double-blind randomized phase 3 trial evaluating chemotherapy (CT) ± atezolizumab (atezo) for early progressing locally advanced/metastatic triple-negative breast cancer (mTNBC).. Journal of Clinical Oncology. 36(15_suppl). TPS1115–TPS1115. 5 indexed citations

Piwko, Charles, et al.. (2015). Safety Profile and Costs of Related Adverse Events of Trastuzumab Emtansine for the Treatment of HER2-Positive Locally Advanced or Metastatic Breast Cancer Compared to Capecitabine Plus Lapatinib from the Perspective of the Canadian Health-Care System. Clinical Drug Investigation. 35(8). 487–493. 5 indexed citations

Pollex, Erika & Janine R. Hutson. (2011). Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents. Expert Opinion on Drug Metabolism & Toxicology. 7(3). 325–339. 11 indexed citations

Pollex, Erika, Myla E. Moretti, Gideon Koren, & Denice S. Feig. (2011). Safety of Insulin Glargine Use in Pregnancy: A Systematic Review and Meta-Analysis. Annals of Pharmacotherapy. 45(1). 9–16. 53 indexed citations

Pollex, Erika, Denice S. Feig, & Gideon Koren. (2010). Oral hypoglycemic therapy: Understanding the mechanisms of transplacental transfer. The Journal of Maternal-Fetal & Neonatal Medicine. 23(3). 224–228. 10 indexed citations

Pollex, Erika, G Anger, Janine R. Hutson, Gideon Koren, & Micheline Piquette‐Miller. (2010). Breast Cancer Resistance Protein (BCRP)-Mediated Glyburide Transport: Effect of the C421A/Q141K BCRP Single-Nucleotide Polymorphism. Drug Metabolism and Disposition. 38(5). 740–744. 46 indexed citations

Pollex, Erika, et al.. (2009). Hypoglycemics: Pharmacokinetic Considerations During Pregnancy. Therapeutic Drug Monitoring. 31(5). 533–541. 8 indexed citations

Pollex, Erika, et al.. (2009). Insulin Glargine Safety in Pregnancy. Diabetes Care. 33(1). 29–33. 68 indexed citations

10.

Pollex, Erika, et al.. (2008). The Role of Placental Breast Cancer Resistance Protein in the Efflux of Glyburide across the Human Placenta. Placenta. 29(8). 743–747. 81 indexed citations

11.

Pollex, Erika, et al.. (2008). Treating the mother – protecting the unborn: The safety of hypoglycemic drugs in pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine. 21(3). 191–196. 6 indexed citations

12.

Ray, Joel G., et al.. (2003). Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel. BMC Cardiovascular Disorders. 3(1). 3–3. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact